Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure

There is little evidence on the use of sodium−glucose cotransporter 2 inhibitors in hospitalised patients. This work aims to analyse the glycaemic and clinical efficacy and safety of empagliflozin continuation in patients with type 2 diabetes hospitalised for acute decompensated heart failure. This...

Full description

Bibliographic Details
Main Authors: Luis M. Pérez-Belmonte, Michele Ricci, Jaime Sanz-Cánovas, Mercedes Millán-Gómez, Julio Osuna-Sánchez, M. Isabel Ruiz-Moreno, M. Rosa Bernal-López, María D. López-Carmona, Manuel Jiménez-Navarro, Juan J. Gómez-Doblas, José P. Lara, Ricardo Gómez-Huelgas
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
type 2 diabetes
heart failure
empagliflozin
hospitalization
Online Access:https://www.mdpi.com/2077-0383/10/16/3540

Internet

https://www.mdpi.com/2077-0383/10/16/3540

Similar Items